Start for free
Start for free
BioAdvance logo

BioAdvance

North America, Pennsylvania, United States, Philadelphia

Description

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.

Investor Profile

BioAdvance has made 197 investments, with 2 in the past 12 months and 12% as lead.

Stage Focus

  • Seed (49%)
  • Series Unknown (27%)
  • Series A (10%)
  • Series B (5%)
  • Debt Financing (4%)
  • Series C (2%)
  • Series D (2%)
  • Post Ipo Equity (1%)
  • Pre Seed (1%)

Country Focus

  • United States (97%)
  • Canada (1%)
  • Russian Federation (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Health Diagnostics
  • Therapeutics
  • Analytics
  • Information Technology
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioAdvance frequently co-invest with?

Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 8
BroadOak Capital Partners
BroadOak Capital Partners
North America, Maryland, United States, Bethesda
Co-Investments: 3
Birchmere Ventures
Birchmere Ventures
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 3
Agent Capital
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Samsara BioCapital
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 3
Safeguard Scientifics
Safeguard Scientifics
North America, Pennsylvania, United States, Radnor
Co-Investments: 5
Bay City Capital
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 3
Biotechnology Value Fund
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 3
Dreamit Ventures
Dreamit Ventures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 4
Research Corporation Technologies
Research Corporation Technologies
North America, Arizona, United States, Tucson
Co-Investments: 3

Which angels does BioAdvance often collaborate with?

SB
Steve Barsh
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 2
PM
Paul McEwan
North America, New York, United States, New York
Shared Deals: 1
JF
Shared Deals: 1
GC
Gary Cohn
North America, New York, United States, New York
Shared Deals: 1
BF
Brad Feld
North America, Colorado, United States, Boulder
Shared Deals: 1
Sohil Shah
Sohil Shah
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
JH
Jeff Heitzman
North America, Illinois, United States, Chicago
Shared Deals: 1
FA
Frank A. Bonsal
North America, Maryland, United States, Baltimore
Shared Deals: 1
PH
Shared Deals: 1
MM
Shared Deals: 1

What are some of recent deals done by BioAdvance?

Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Post Ipo EquityDec 13, 2024

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

Biotechnology
SeedOct 15, 2024
Amount Raised: $20,200,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
Series UnknownNov 14, 2023
Amount Raised: $15,000,000
KayoThera

Princeton, New Jersey, United States

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

BiotechnologyHealth CareMedical
Series AJul 19, 2023
Amount Raised: $5,200,000
Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Series DJan 5, 2023
Amount Raised: $37,700,000
Senzo

San Francisco, California, United States

Senzo is a deep-tech bio-med company developing testing products and IP.

BiotechnologyHealth CareHealth DiagnosticsInformation Technology
SeedDec 12, 2022
Amount Raised: $1,900,000
Innervace

Philadelphia, Pennsylvania, United States

Innvervace develops regenerative therapy solutions for neurodegenerative disorders.

BiotechnologyHealth CareMedicalNeuroscience
Series ASep 8, 2022
Amount Raised: $40,000,000
Senzo

San Francisco, California, United States

Senzo is a deep-tech bio-med company developing testing products and IP.

BiotechnologyHealth CareHealth DiagnosticsInformation Technology
SeedJul 21, 2022
Amount Raised: $2,000,000
Halo Labs

Philadelphia, Pennsylvania, United States

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

AnalyticsBiopharmaBiotechnologyHealth DiagnosticsPharmaceutical
Series CJul 11, 2022
Amount Raised: $6,999,990
KayoThera

Princeton, New Jersey, United States

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

BiotechnologyHealth CareMedical
Series AMar 16, 2022
Amount Raised: $8,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator